Navigation Links
DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate)
Date:11/17/2011

ull prescribing information and visit the DEXILANT Website at www.DEXILANT.com.  

Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and gastroenterology treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for diabetes, cardiovascular disease, gastroenterology, neurology and other conditions. To learn more about these Takeda companies, visit www.tpna.com.  

This press release contains forward-looking statements about Takeda. Forward-looking statements include statements regarding Takeda's plans, outlook, strategies, results for the future, and other statements that are not descriptions of historical facts. Forward-looking statements may be identified by the use of forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "assume," "continue," "seek," "pro forma," "potential," "target," "forecast," "guidance," "outlook" or "intend" or other similar words or expressions of the negative thereof. Forward-looking statements are based on estimates and assumptions made by management that are believed to be reasonable, though they are inherently uncertain and difficult to predict. Investors are cautioned not to unduly rely on such forward-looking statements.

Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements. Some of these risks and
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
2. Data Presented at DDW About Rebound Symptoms in Healed Erosive Esophagitis Patients After Completion of Treatment with DEXILANT(TM) (dexlansoprazole)
3. Proton Pump Inhibitor DEXILANT(TM) (dexlansoprazole) Now Available in U.S. Pharmacies
4. KAPIDEX(TM) (dexlansoprazole) Renamed DEXILANT(TM) in U.S. to Avoid Name Confusion
5. New Study Results Analyzed the Use of KAPIDEX(TM) (dexlansoprazole) for Nighttime Heartburn in Adults with Non-Erosive GERD
6. White Smile Global Inc. Corporate Update on the White Smile Premier™ "At-Home" LED Teeth Whitening System and the White Smile Tooth Gloss™, Including Clinical Study, Product Manufacturing, and Distribution
7. 72 Prominent Personalized Medicine Products Available; A Five-Fold Increase in Five Years
8. Novation Awards ICU Medical, Inc. a New Contract to Supply Members With a Complete Line of Clinically-Preferred Critical Care Products
9. Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC
10. Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH
11. Apelon Provides Products and Services to Support Canadian Healthcare Data Standardization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 20, 2014 Depomed, Inc. (NASDAQ: ... the Piper Jaffray 26 th Annual Healthcare Conference in ... the Piper Jaffray conference is scheduled for 8:00 am EST (5:00 ... webcast, and the webcast can be accessed via the Investor Relations ... of the webcast will be archived for 30 days on the ...
(Date:11/21/2014)... THE WOODLANDS, Texas , Nov. 21, 2014 /PRNewswire/ ... announced the pricing of its previously announced underwritten public ... pursuant to an effective shelf registration statement. The offering ... a public offering price of $1.005 per share.  Lexicon ... purchase up to 7,462,687 additional shares of common stock.  ...
(Date:11/18/2014)... Nov. 18, 2014  Sanguine Biosciences – a ... and study recruitment – will use its proprietary ... help Pfizer Inc. find and recruit people diagnosed ... family members to participate in voluntary research, which ... mutations and hopefully aid in informing the development ...
Breaking Medicine Technology:Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2
(Date:11/21/2014)... November 21, 2014 Recently, TideStore.com, a ... accessories, has announced its special offer TideStore Thanksgiving ... items at TideStore.com are now provided with big discounts. ... 25. People can enjoy an extra 10% discount with ... their email addresses and have opportunities to win free ...
(Date:11/21/2014)... 2014 According to a National Highway ... 11th, 2014, the inflating system found in certain airbags ... inflates. The force of inflation may cause the metal ... shards may pierce the airbag’s fabric and potentially cause ... According to a Bloomberg Business Week article ...
(Date:11/21/2014)... By Dennis Thompson ... -- Overweight or obese women who get pregnant are much ... disease as an adult, new research suggests. But it ... in that trend, the researchers added. "Mothers who are ... study author Dr. Michael Mendelson. He is a research fellow ...
(Date:11/21/2014)... Reinberg HealthDay Reporter THURSDAY, ... to excess or binge drink are not alcoholics, a new ... those who drink too much aren,t dependent on alcohol. But ... U.S. Centers for Disease Control and Prevention. , , "A lot ... are alcoholics," said study co-author Dr. Robert Brewer, the leader ...
(Date:11/18/2014)... 18, 2014 Examination Management Services, ... risk management and investigative services, has launched a ... Model to enhance its paramedical exam service to ... Through use of EMSI’s 5 Star Examiner Performance ... their paramedical exams are conducted by examiners whose ...
Breaking Medicine News(10 mins):Health News:Thanksgiving Sales from TideStore.com 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3Health News:Kids Born to Overweight Moms May Face Higher Heart Risks as Adults 2Health News:Many People Who Drink a Lot Aren't Alcoholics: CDC 2Health News:Many People Who Drink a Lot Aren't Alcoholics: CDC 3Health News:EMSI Launches Proprietary 5 Star Examiner Performance Model to Enhance Paramedical Exam Service 2
... in training have a 17 percent less chance of ... surgery at non-teaching hospitals, according to results of a ... the Annals of Thoracic Surgery. , Theres a ... because of training issues, and concerns are frequently voiced ...
... Senate Letter asks Lawmakers to Reject Funding Reductions ... Reform Much More,Difficult to Achieve, Letter Draws ... March 4 The Council for Quality,Respiratory Care ... home oxygen,therapy providers and manufacturers who provide care ...
... and TORONTO, March 4 /PRNewswire/ - Affinium Pharmaceuticals,today ... healthy subjects in,a Phase I study of AFN-1252, ... class of fatty acid biosyntheis inhibitors. The study ... of a single,escalating oral dose. Affinium believes that ...
... Data from one of the first genome-wide association studies ... in part by The Michael J. Fox Foundation for ... researchers through the National Human Genome Research Institute (NHGRI) ... of the National Institutes of Health (NIH). NHGRI hopes ...
... experience a significant improvement in their quality of ... new research published in the March 2008 issue ... The German study evaluated the quality of life ... Cochlear Implant Questionnaire (NCIQ), a self-administered assessment that ...
... the users risk of head and neck cancer, according to ... Otolaryngology Head and Neck Surgery. , The small sample ... found that among 75 cases of head and neck cancer, ... neck cancer in marijuana users was the same (1.0) as ...
Cached Medicine News:Health News:Risk of surgery for lung cancer lower at teaching hospitals 2Health News:Bi-Partisan Members of United States Senate Formally Raise Concerns About Proposed Cuts to Medicare's Home Oxygen Benefit 2Health News:Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic 2Health News:Genome-wide association study on Parkinson's disease finds public home at NIH 2Health News:Genome-wide association study on Parkinson's disease finds public home at NIH 3Health News:Genome-wide association study on Parkinson's disease finds public home at NIH 4Health News:Genome-wide association study on Parkinson's disease finds public home at NIH 5
Using proven 1064 nm technology for the treatment of deeper lesions, the Lumenis One Multi-Spot Nd:YAG module provides versatility allowing targeted treatment of leg veins, vascular lesions, facial w...
... people are diagnosed with varicose veins every ... never seek treament and are apprehensive of ... them an effective alternative to conventional therapies., ... hook phlebectomy), is considered a laborious procedure ...
Inquire...
...
Medicine Products: